Turn Evidence Into a Convincing Value Story
Bring clinical, economic and organizational evidence into one coherent value narrative.
JCA Requirements for Medical Devices and In-Vitro Diagnostic Devices
Gain a comprehensive understanding of the key methodological and evidence requirements for medical device and IVD manufacturers preparing for EU JCA
Recent news and posts
EU HTA Publication Digest: From Joint Clinical Assessment to National Decisions: EU HTA Implementation and Implications for Patient Access
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest.
In a recent publication, D'Oca et al. explored early national perspectives on the implementation of Joint Clinical Assessments (JCA) under the EU HTA Regulation. The analysis was based on surveys of HTA and market access representatives across 25 European countries. Respondents reported mixed expectations regarding the impact of JCA on reimbursement timelines, while emphasizing the need for greater transparency in PICO consolidation and clearer integration of JCA reports into national appraisals. The findings suggest that JCA may reshape, rather than centralize, evidence assessment by shifting national influence to earlier stages of the HTA process.
Access the full-text article here.